erythrosine has been researched along with primaquine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ekowati, J; Hendradi, E; Miatmoko, A; Nehru, NF; Nurjannah, I; Rosita, N; Sari, R | 1 |
| Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
2 other study(ies) available for erythrosine and primaquine
| Article | Year |
|---|---|
Interactions of primaquine and chloroquine with PEGylated phosphatidylcholine liposomes.
Topics: Antimalarials; Chemistry, Pharmaceutical; Chloroquine; Cholesterol; Drug Compounding; Drug Liberation; Fluoresceins; Humans; Liposomes; Malaria; Nanoparticles; Pharmaceutical Vehicles; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; Primaquine; X-Ray Diffraction | 2021 |
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |